Literature DB >> 16100422

Susceptibility trends of pseudomonas species from corneal ulcers.

S Smitha1, P Lalitha, V N Prajna, M Srinivasan.   

Abstract

PURPOSE: To assess the changing trends in the antibiotic susceptibility of Pseudomonas spp . isolated from bacterial keratitis over a nine year period with special emphasis on fluoroquinolone susceptibilities.
METHODS: All corneal scraping cultures positive for Pseudomonas spp. (n=585) isolated from patients with bacterial keratitis at the Aravind Eye Hospital, Madurai from 1995-2003 were evaluated. Cultures were performed in liquid and solid media and susceptibility testing was done against amikacin, gentamicin, tobramycin, ciprofloxacin and ofloxacin by Kirby-Bauer disc diffusion method.
RESULTS: The susceptibility of Pseudomonas spp. was over 90% from 1995-1998 to ciprofloxacin which decreased to 83% from 1999-2003. The total number of isolates resistant to ciprofloxacin was 51 (9.4%). No statistically significant increase in the number of isolates resistant to ciprofloxacin was noted. Ofloxacin showed 54% susceptibility from 1995-1998 but increased to 64% from 1999-2003. Analysis of in vitro activity of amikacin reveals that there was 43% sensitivity from 1995-1998 but later it increased to 76% from 1999-2003. In case of gentamicin, the sensitivity decreased marginally from 80% to 70% through the years. Tobramycin showed 45% sensitivity from 1995-1998 but increased to 75% from 1999-2003.
CONCLUSIONS: The fluoroquinolones remain a good choice in the treatment of ocular infections, with high susceptibility of Pseudomonas spp. Among the aminoglycosides, gentamicin was found to be highly effective against Pseudomonas corneal ulcers when compared to amikacin and tobramycin. The results show a need for continuous monitoring of bacterial resistance trends.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100422     DOI: 10.4103/0255-0857.16588

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  5 in total

1.  Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.

Authors:  Jia A Mei; William Johnson; Bailey Kinn; Emily Laskey; Lydia Nolin; Pratham Bhamare; Charlotte Stalker; Paul M Dunman; Rachel A F Wozniak
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

2.  Aminoglycoside Resistance in Clinical Isolates of Gram Negative Bacilli at the University Hospital of the West Indies, Jamaica: Comparison of Two Time Periods.

Authors:  G Reynolds-Campbell; A Nicholson; N Christian; R Hardie; J Cook
Journal:  West Indian Med J       Date:  2015-02-12       Impact factor: 0.171

3.  Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones.

Authors:  Durga S Borkar; Nisha R Acharya; Chelsia Leong; Prajna Lalitha; Muthiah Srinivasan; Catherine E Oldenburg; Vicky Cevallos; Thomas M Lietman; David J Evans; Suzanne M J Fleiszig
Journal:  BMC Ophthalmol       Date:  2014-04-24       Impact factor: 2.209

4.  Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India.

Authors:  Viren A Javiya; Somsuvra B Ghatak; Kamlesh R Patel; Jagruti A Patel
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

5.  Spectrum of bacterial keratitis at a tertiary eye care centre in India.

Authors:  Jayaraman Kaliamurthy; Catti Muniswamy Kalavathy; Pragya Parmar; Christadas Arul Nelson Jesudasan; Philip A Thomas
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.